pneumoniae-positive patients (B) and with a pool of 10 healthy blood donors (C). Lanes: 1, standard protein marker; 2, induced rAtpD (about 50 kDa); 3, induced rP1-C (about 40 kDa); 4, purified rAtpD; 5, purified rP1-C; 6, irrelevant his-tagged protein of the same mass as rAtpD; 7, irrelevant his-tagged protein of the same mass as r P1-C. The numbers on the left indicate molecular masses (in kDa). The rAtpD and rP1-C proteins were both recognised by pooled M. pneumoniae-positive serum samples (Fig. 2B, lanes 2 and 4 for rAtpD, lanes 3 and 5 for rP1-C), but not by healthy blood donors (Fig. 2C, lanes

2 and AZD3965 ic50 4 for rAtpD, lanes 3 and 5 for rP1-C). The two irrelevant proteins were not recognised by serum samples from either patients or healthy blood donors (Fig. 2B and 2C, lanes 6 and 7). These results show that M. pneumoniae-infected patients have circulating anti-AtpD and anti-rP1 -C antibodies, thereby confirming that these two recombinant proteins are BVD-523 nmr antigenic. rAtpD and rP1-C ELISA tests Serum samples from 103 patients (54 children, 49 adults) with M. pneumoniae RTIs and 86 healthy blood donors were screened for anti-M. pneumoniae IgM, IgA and IgG antibodies using an

in-house ELISA with rAtpD and rP1-C (Tables 2 and 3). We set positive criteria as a value 3-deazaneplanocin A cost above the cut-off determined by receiver operating characteristics curve (ROC) analysis. The cut-off values of the IgM, IgA and IgG ELISA tests were determined as an absorbance value of 0.4, 0.2, and 0.4, respectively, for rAtpD, and of 0.4, 0.5 and 0.4, respectively for rP1-C. The rAtpD protein demonstrated a higher discriminating score (0.842 ≤ area under curve (AUC) Ponatinib ≤ 0.943) than rP1-C for all of the Ig classes in children and adults (Tables

2 and 3). Among the 54 serum samples from children tested, 38 (70%) showed a high IgM titre compared with rAtpD, whereas 30 (56%) were IgA-positive and 42 (78%) were IgG-positive. Serum samples from 38 (70%) children were positive for IgM against the rP1-C protein, whereas 27 (50%) and 37 (69%) were IgA- and IgG-positive, respectively (Table 2). Out of the 49 serum samples from adults infected with M. pneumoniae, 33 (67%) and 22 (45%) tested positive for IgM antibodies against the rAtpD and rP1-C proteins, respectively. Of these samples, 32 (65%) and 27 (55%) reacted with the rAtpD and rP1-C proteins, respectively, for the IgA class, whereas 30 (61%) and 22 (45%) were IgG-positive for the rAtpD and rP1-C proteins, respectively (Table 3). Specificity values ranging from 90% to 97% were found for IgM, IgA and IgG rAtpD and rP1-C protein ELISAs, meaning that no more than 3% to 10% of the serum samples from healthy donors had absorbance values above the cut-off (Tables 2 and 3). Table 2 Performance of the rAtpD, rP1-C ELISAs and the Ani Labsystems kit in children Ig class Type of test No.